SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DIACOUSTIC MEDICAL DEVICES (PTY)
VS

AI Verdict

Tool A is designed to assist physicians in diagnosing heart murmurs by classifying acoustic heart signals. In contrast, Tool B focuses on the early detection of low ejection fraction, a key indicator of heart failure, by analyzing ECG and heart sound recordings. While both are FDA-cleared AI tools for cardiac clinical decision support using stethoscope data, they address different specific diagnostic objectives.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if your primary goal is to differentiate between physiological and pathological heart murmurs. This tool is ideal for clinicians who need AI-powered assistance in classifying suspected murmurs based on acoustic heart signals, complementing their auscultation skills.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your priority is the early detection and screening of low ejection fraction, a key indicator of heart failure, during routine physical examinations. This tool is best suited for clinicians looking to quickly identify patients at risk for heart failure using an integrated AI algorithm with their Eko digital stethoscope.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION Eko Low Ejection Fraction Tool (ELEFT)
Pricing Contact for pricing Unknown
Deployment Hosted server environment (Linux OS) with a mobile application interface Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Low Ejection Fraction Tool (ELEFT)

Eko's ELEFT integrates seamlessly with its own digital stethoscopes and offers cloud-based processing with rapid results in approximately 15 seconds, providing a cohesive user experience. SensiCardiac Mobi requires a user-provided compatible electronic stethoscope and a hosted server environment, which may introduce more setup complexity.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

While both are FDA-cleared decision support tools, ELEFT's focus on the early detection of low ejection fraction directly addresses a critical indicator for heart failure, enabling proactive patient management. SensiCardiac Mobi's differentiation of heart murmurs is also valuable, but ELEFT's specific targeting of a major disease risk factor offers a potentially higher impact on patient outcomes.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, and neither provides publicly available details or pricing models. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

Eko's ELEFT is explicitly stated to be part of the SENSORAu2122 platform, an enterprise solution, and leverages a cloud-based deployment model, indicating strong scalability and integration capabilities for large healthcare systems. Both tools are HIPAA compliant and offer BAAs, but Eko's platform approach suggests a more mature enterprise offering.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT demonstrates greater innovation by combining AI-powered analysis of both ECG and heart sound recordings for low ejection fraction detection, delivering results in a rapid 15 seconds. SensiCardiac Mobi's AI for murmur differentiation is innovative, but Eko's multi-modal data analysis and speed for a critical condition represent a more advanced application of AI in cardiac screening.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko Health provides a comprehensive Help Center with various support channels, including live Q&A, scheduled calls, email support, and extensive online documentation and user manuals. In contrast, readily accessible and detailed support resources for SensiCardiac Mobi are less apparent from public information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION Eko Low Ejection Fraction Tool (ELEFT)
Name SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION Eko Low Ejection Fraction Tool (ELEFT)
Primary AI Function Assists physicians in diagnosing heart murmurs by differentiating between physiological and pathological sounds. Aids clinicians in the early detection of low ejection fraction, an indicator of heart failure.
Company DIACOUSTIC MEDICAL DEVICES (PTY) Eko Health
Required Hardware Compatible electronic stethoscope (user-provided), Mobile application for data capture and display (e.g., iPhone 4S or later) FDA-cleared Eko digital stethoscopes
Specialties Cardiology, Internal Medicine, Pediatrics Cardiology, Family Medicine, Internal Medicine
Platform Integration Not specified Part of the SENSORAu2122 Cardiac Early Detection Platform

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SensiCardiac Mobi assists in diagnosing heart murmurs by differentiating physiological from pathological sounds, making it valuable for Cardiology, Internal Medicine, and Pediatrics. Eko Low Ejection Fraction Tool focuses on the early detection of low ejection fraction, a key indicator of heart failure, primarily benefiting Cardiology, Family Medicine, and Internal Medicine.
SensiCardiac Mobi operates via a mobile application for data capture and display and requires a user-provided compatible electronic stethoscope. The Eko Low Ejection Fraction Tool integrates directly with FDA-cleared Eko digital stethoscopes and is part of the SENSORAu2122 platform, providing results in approximately 15 seconds.
SensiCardiac Mobi analyzes acoustic heart signals to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs. The Eko Low Ejection Fraction Tool uses AI to detect low ejection fraction (LVEF u2264 40%), a critical indicator of heart failure, by analyzing ECG and heart sound recordings.
SensiCardiac Mobi uses a mobile application for data capture and display, which suggests a familiar interface for many users. The Eko Low Ejection Fraction Tool integrates with Eko digital stethoscopes and delivers results in approximately 15 seconds, indicating a rapid turnaround for clinical insights during an exam.
SensiCardiac Mobi relies on a mobile application and a hosted server environment, which would require managing mobile device distribution and server access across sites. The Eko Low Ejection Fraction Tool is cloud-based and part of the SENSORAu2122 platform, potentially streamlining multi-site deployment and centralized data management.
SensiCardiac Mobi acquires and records acoustic heart signals at four main auscultation positions, providing data that can be used for clinical documentation. The Eko Low Ejection Fraction Tool analyzes ECG and heart sound recordings, and as part of a clinical decision support platform, it would generate auditable results for integration into patient records.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.